BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints (Q6629374)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints |
scientific article; zbMATH DE number 7935576
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints |
scientific article; zbMATH DE number 7935576 |
Statements
BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints (English)
0 references
29 October 2024
0 references
Bayesian optimal design
0 references
biosimilar
0 references
co-primary endpoints
0 references
power
0 references
sequential design
0 references
0 references
0 references
0 references
